NCT02595905 2026-04-08Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesNational Cancer Institute (NCI)Phase 2 Completed344 enrolled 11 charts